HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Stephanie Newman Selected Research

Inositol 1,4,5-trisphosphate 3-kinase

9/2020ITPKC as a Prognostic and Predictive Biomarker of Neoadjuvant Chemotherapy for Triple Negative Breast Cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Stephanie Newman Research Topics

Disease

3Neoplasms (Cancer)
09/2020 - 01/2019
2Breast Neoplasms (Breast Cancer)
09/2020 - 01/2020
2Inflammation (Inflammations)
09/2020 - 01/2020
1Triple Negative Breast Neoplasms
09/2020
1Mucocutaneous Lymph Node Syndrome (Kawasaki Disease)
09/2020
1Neoplasm Metastasis (Metastasis)
09/2020

Drug/Important Bio-Agent (IBA)

1Biomarkers (Surrogate Marker)IBA
09/2020
1Inositol 1,4,5-trisphosphate 3-kinaseIBA
09/2020
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
09/2020
1InterleukinsIBA
09/2020
1SolutionsIBA
01/2020
1TNF Receptor-Associated Factor 6 (TRAF6)IBA
01/2019

Therapy/Procedure

2Neoadjuvant Therapy
09/2020 - 09/2020